Critical Illness Clinical Trial
— INPUTOfficial title:
Implementation of Nudges to Promote Utilization of Low Tidal Volume Ventilation (INPUT) Study
Verified date | February 2024 |
Source | University of Pennsylvania |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study is a large pragmatic stepped-wedge trial of electronic health record (EHR)-based implementation strategies informed by behavioral economic principles to increase lung-protective ventilation (LPV) utilization among all mechanically ventilated (MV), adult patients. The study will compare the standard approach to managing MV across 12 study Intensive Care Units (ICUs) within University of Pennsylvania Health System (UPHS) versus interventions prompting physicians and respiratory therapists (RTs) to employ LPV settings promote LPV utilization among all MV patients.
Status | Completed |
Enrollment | 6941 |
Est. completion date | December 15, 2023 |
Est. primary completion date | June 15, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 99 Years |
Eligibility | Inclusion Criteria: 1. Aged 18 and over; AND 2. Admission to 1 of the 12 participating ICUs; AND 3. Undergoing mechanical ventilation Exclusion Criteria: 1. The episode of MV lasts less than 12 hours, because we believe that the evidence-based practice may not apply to these patients nor alter their outcomes. 2. The patient is on minimal settings for the entirety of MV, defined as a spontaneous mode (e.g., pressure support ventilation) with pressure support <10 Centimeters of Water Column (cmH2O), AND positive end-expiratory pressure (PEEP) <8 cmH20, AND fraction of inspired oxygen (FiO2) <50%, because the clinical significance of spontaneous tidal volumes is unknown and low tidal volumes may not be beneficial or desirable. 3. Goals of care are documented as comfort measures only (as identified through their "code status" field in the EHR) during the first 72 hours during episode of MV, because mechanical ventilation is managed differently during care focused exclusively on comfort and low tidal volume ventilation may not be appropriate, nor would it likely influence clinical outcomes. 4. There is no height documented in the EHR at the time of initiation of MV, because we will be unable to estimate ideal body weight, a necessary parameter to calculate the primary outcome, and because they will not receive the interventions. 5. The height documented is less than 4 feet, because the formula for ideal body weight does not hold true below this height. |
Country | Name | City | State |
---|---|---|---|
United States | Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania |
United States | Penn Presbyterian Medical Center | Philadelphia | Pennsylvania |
United States | Pennsylvania Hospital | Philadelphia | Pennsylvania |
United States | Princeton Medical Center | Plainsboro | New Jersey |
United States | Chester County Hospital | West Chester | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
University of Pennsylvania | National Heart, Lung, and Blood Institute (NHLBI) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | fidelity to LPV | percentage of time that a patient is exposed to tidal volume <6.5 cc/kg ideal body weight (hours) | first 72 hours of mechanical ventilation, during study intervention period | |
Primary | sustainability | the percentage of time that a patient is exposed to tidal volume <6.5 cc/kg ideal body weight (IBW) among MV patients (hours) | first 72 hours of mechanical ventilation, during study observation period | |
Secondary | Total duration of exposure to tidal volume >8 cc/kg and >10 cc/kg IBW | Total duration of exposure to tidal volume >8 cc/kg and >10 cc/kg IBW (hours) | from initiation to discontinuation of mechanical ventilation, average of 72 hours | |
Secondary | hospital mortality | patient mortality occurring during hospitalization | from hospital admission to hospital discharge, average of 120 hours | |
Secondary | ICU length of stay | ICU length of stay (hours) | from time of first eligibility to ICU discharge, average of 120 hours | |
Secondary | hospital length of stay | hospital length of stay (hours) | from time of first eligibility to hospital discharge, average of 264 hours | |
Secondary | hospital discharge disposition | patient disposition at time of hospital discharge | through time of hospital discharge, average of 264 hours | |
Secondary | mechanical ventilation duration | mechanical ventilation duration (hours) | from initiation to discontinuation of mechanical ventilation, average of 72 hours | |
Secondary | initial tidal volume administered | initial tidal volume (cc/kg) | at time of mechanical ventilation initiation, average of 72 hours | |
Secondary | Duration of time exposed to plateau pressure (Pplat)>30 mmHg | Duration of time exposed to plateau pressure (Pplat)>30 mmHg (hours) | from initiation to discontinuation of mechanical ventilation, average of 72 hours | |
Secondary | total cumulative doses of sedative medications during and after mechanical ventilation | Total cumulative doses of sedative medications during and after mechanical ventilation | from initiation of mechanical ventilation to hospital discharge, average of 264 hours | |
Secondary | Total number of days with acute brain dysfunction during hospitalization | Total number of days with acute brain dysfunction during hospitalization, during and after mechanical ventilation | from initiation of mechanical ventilation to hospital discharge, average of 264 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04551508 -
Delirium Screening 3 Methods Study
|
||
Recruiting |
NCT06037928 -
Plasma Sodium and Sodium Administration in the ICU
|
||
Completed |
NCT03671447 -
Enhanced Recovery After Intensive Care (ERIC)
|
N/A | |
Recruiting |
NCT03941002 -
Continuous Evaluation of Diaphragm Function
|
N/A | |
Recruiting |
NCT04674657 -
Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
|
||
Completed |
NCT04239209 -
Effect of Intensivist Communication on Surrogate Prognosis Interpretation
|
N/A | |
Completed |
NCT05531305 -
Longitudinal Changes in Muscle Mass After Intensive Care
|
N/A | |
Terminated |
NCT03335124 -
The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock
|
Phase 4 | |
Completed |
NCT02916004 -
The Use of Nociception Flexion Reflex and Pupillary Dilatation Reflex in ICU Patients.
|
N/A | |
Recruiting |
NCT05883137 -
High-flow Nasal Oxygenation for Apnoeic Oxygenation During Intubation of the Critically Ill
|
||
Completed |
NCT04479254 -
The Impact of IC-Guided Feeding Protocol on Clinical Outcomes in Critically Ill Patients (The IC-Study)
|
N/A | |
Recruiting |
NCT04475666 -
Replacing Protein Via Enteral Nutrition in Critically Ill Patients
|
N/A | |
Not yet recruiting |
NCT04538469 -
Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
|
||
Not yet recruiting |
NCT04516395 -
Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae
|
N/A | |
Withdrawn |
NCT04043091 -
Coronary Angiography in Critically Ill Patients With Type II Myocardial Infarction
|
N/A | |
Recruiting |
NCT02922998 -
CD64 and Antibiotics in Human Sepsis
|
N/A | |
Recruiting |
NCT02989051 -
Fluid Restriction Keeps Children Dry
|
Phase 2/Phase 3 | |
Completed |
NCT02899208 -
Can an Actigraph be Used to Predict Physical Function in Intensive Care Patients?
|
N/A | |
Completed |
NCT03048487 -
Protein Consumption in Critically Ill Patients
|
||
Recruiting |
NCT02163109 -
Oxygen Consumption in Critical Illness
|